Cubist Systematic Strategies’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-20,123
| Closed | -$1.11M | – | 4207 |
|
|
2022
Q2 | $1.11M | Sell |
20,123
-25,007
| -55% | -$1.38M | 0.01% | 2054 |
|
|
2022
Q1 | $1.45M | Buy |
+45,130
| New | +$1.45M | 0.01% | 1751 |
|
|
2019
Q2 | – | Sell |
-89
| Closed | -$6K | – | 2642 |
|
|
2019
Q1 | $6K | Sell |
89
-67
| -43% | -$4.52K | ﹤0.01% | 2203 |
|
|
2018
Q4 | $8K | Sell |
156
-69
| -31% | -$3.54K | ﹤0.01% | 1991 |
|
|
2018
Q3 | $15K | Buy |
225
+12
| +6% | +$800 | ﹤0.01% | 1788 |
|
|
2018
Q2 | $25K | Sell |
213
-143
| -40% | -$16.8K | ﹤0.01% | 1698 |
|
|
2018
Q1 | $29K | Buy |
356
+136
| +62% | +$11.1K | ﹤0.01% | 1737 |
|
|
2017
Q4 | $33K | Buy |
220
+203
| +1,194% | +$30.5K | ﹤0.01% | 1811 |
|
|
2017
Q3 | $1K | Buy |
+17
| New | +$1K | ﹤0.01% | 1816 |
|